COLUMVI
COLUMVI
Approved
DIN Number
02536560
Drug Class
Human
Market Date
Jul 5, 2023
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02536560
AIG Number0164522001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FX28 GLOFITAMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLOFITAMABActive
Strength: 10 MG / 10 ML
Monograph: GLOFITAMAB